ROIVANT SCIENCES LTD. Non Peo Neo Avg Comp Actually Paid Amt
ROIVANT SCIENCES LTD. (ROIV) reported Non Peo Neo Avg Comp Actually Paid Amt of $230.82 million for the 12-month period ending 2026-03-31, per its DEF 14A filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-07-29
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2026-03-31 | $230.82M DEF 14A · filed 2026-07-29 |
| 2025-03-31 | $43.16M DEF 14A · filed 2026-07-29 |
| 2024-03-31 | $8.13M DEF 14A · filed 2026-07-29 |
| 2023-03-31 | $97.82M DEF 14A · filed 2026-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |